Lido Advisors, LLC Takeda Pharmaceutical CO LTD Transaction History
Lido Advisors, LLC
- $21.7 Billion
- Q4 2024
A detailed history of Lido Advisors, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Lido Advisors, LLC holds 27,487 shares of TAK stock, worth $380,969. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,487Holding current value
$380,969% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TAK
# of Institutions
338Shares Held
68.6MCall Options Held
1.72MPut Options Held
178K-
Capital Research Global Investors Los Angeles, CA13.2MShares$182 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.6MShares$77.6 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$64.1 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$58.4 Million0.05% of portfolio
-
First Trust Advisors LP Wheaton, IL3.24MShares$44.9 Million0.04% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.1B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...